Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 55: 723-729, 2009. First published January 30, 2009; 10.1373/clinchem.2008.113050
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2008.113050v1
55/4/723    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shekhtman, E. M.
Right arrow Articles by Umansky, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shekhtman, E. M.
Right arrow Articles by Umansky, S. R.
(Clinical Chemistry. 2009;55:723-729.)
© 2009 American Association for Clinical Chemistry, Inc.

Molecular Diagnostics and Genetics

Optimization of Transrenal DNA Analysis: Detection of Fetal DNA in Maternal Urine

Eugene M. Shekhtman1, Kalpana Anne1, Hovsep S. Melkonyan1, David J. Robbins1, Steven L. Warsof2 and Samuil R. Umansky1,a

1 Xenomics Inc., Monmouth Junction, NJ; 2 Eastern Virginia Medical School, Norfolk, VA.

aAddress correspondence to this author at: Xenomics Inc., 1 Deer Park Dr., Suite F, Monmouth Junction, NJ 08852. Fax 732-438-8299; e-mail sumansky{at}xenomics.com.

Background: Fragments of DNA from cells dying throughout the body are detectable in urine (transrenal DNA, or Tr-DNA). Our goal was the optimization of Tr-DNA isolation and detection techniques, using as a model the analysis of fetal DNA in maternal urine.

Methods: We isolated urinary DNA using a traditional silica-based method and using a new technique based on adsorption of cell-free nucleic acids on Q-Sepharose resin. The presence of Y chromosome–specific SRY (sex-determining region Y) sequences in urine of pregnant women was detected by conventional and real-time PCR using primers/probe sets designed for 25-, 39-, 65-, and 88-bp PCR targets.

Results: Method of DNA isolation and PCR target size affected fetal Tr-DNA detection. Assay diagnostic sensitivity increases as the PCR target is shortened. Shorter DNA fragments (50–150 bp) could be isolated by Q-resin–based technique, which also facilitated fetal Tr-DNA analysis. Using DNA isolated by Q-resin–based method and an "ultrashort" DNA target, we successfully detected SRY sequences in 78 of 82 urine samples from women pregnant with male fetuses (positive predictive value 87.6%). Eleven of 91 urine samples from women pregnant with female fetuses produced SRY false-positive results (negative predictive value 95.2%).

Conclusions: Single-copy fetal DNA sequences can be successfully detected in the urine of pregnant women when adequate methods for DNA isolation and analysis are applied. Strong precautions against sample contamination with male cells and DNA are necessary to avoid false-positive results.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
M. Bauer and B. Pertl
On Targeting Cell-Free DNA in Urine: A Protocol for Optimized DNA Analysis
Clin. Chem., April 1, 2009; 55(4): 605 - 606.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Association for Clinical Chemistry.